Silo Pharma shareholders approved authorized common share increase at annual meeting

• Silo Pharma held its annual shareholder meeting on Aug. 14, 2026.
• Shareholders backed a charter amendment raising authorized common stock to 250,000,000 shares from 6,666,667 shares.
• The company executed that decision by filing a certificate of amendment to its articles of incorporation on Aug. 14, 2026.
• Investors ratified Salberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders also authorized adjournment of the meeting if needed to solicit additional proxies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-090748), on August 17, 2026, and is solely responsible for the information contained therein.